23 May 2013
Keywords: new, hiv, drugs, raise, funding, specter, uk
Article | 28 October 1996
As reported in the Marketletter last week, Roche's Invirase (saquinavir) has become the second HIV protease inhibitor to be made ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.